Guzmán Alonso
Impact in
-
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 12
- Ferroptosis and cancer prognosis 4
- Advanced Breast Cancer Therapies 3
- Co-authors
- Vivek Subbiah (7 shared papers)Benjamin Solomon (4 shared papers)Filippo de Braud (4 shared papers)Benjamin Besse (3 shared papers)Keunchil Park (3 shared papers)Victoria Soldatenkova (4 shared papers)Oliver Gautschi (4 shared papers)Alexander Drilon (3 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Annals of Oncology (7 papers)Journal for ImmunoTherapy of Cancer (1 paper)Nutrients (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Guzmán Alonso
30 papers receiving 324 citations
Guzmán Alonso's Hit Papers
Peers
Comparison fields: 5 of 45
- Oncology 148
- Pulmonary and Respiratory Medicine 151
- Cancer Research 64
- Endocrinology, Diabetes and Metabolism 38
- Immunology 36
Countries citing papers authored by Guzmán Alonso
This map shows the geographic impact of Guzmán Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guzmán Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guzmán Alonso more than expected).
Fields of papers citing papers by Guzmán Alonso
This network shows the impact of papers produced by Guzmán Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guzmán Alonso. The network helps show where Guzmán Alonso may publish in the future.
Co-authors
The 25 scholars most cited alongside Guzmán Alonso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial Hit paper breakdown → | 2022 | 129 |
| 2 | 2020 | 44 | |
| 3 | 2021 | 29 | |
| 4 | 2023 | 17 | |
| 5 | 2022 | 14 | |
| 6 | 2023 | 11 | |
| 7 | 2021 | 10 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 7 | |
| 10 | 2021 | 7 | |
| 11 | 2007 | 6 | |
| 12 | 2024 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2025 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2009 | 3 | |
| 20 | 2024 | 3 |
About Guzmán Alonso
Guzmán Alonso is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Immunology, having authored 37 papers that have together received 332 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (6 papers), Ferroptosis and cancer prognosis (4 papers), Lung Cancer Research Studies (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Advanced Breast Cancer Therapies (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Oncology (148 citations), Pulmonary and Respiratory Medicine (151 citations), Cancer Research (64 citations), Endocrinology, Diabetes and Metabolism (38 citations) and Immunology (36 citations). Guzmán Alonso has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Vivek Subbiah, Benjamin Solomon, Filippo de Braud, Benjamin Besse, Keunchil Park, Victoria Soldatenkova, Oliver Gautschi, Alexander Drilon, Kōichi Goto and Herbert H. Loong. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Nutrients and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.